A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)

Clinical trial NCT00746317 · COMPLETED

Trial details

NCT number: NCT00746317
Sponsor: Chugai Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic HCC

Start date: 2008-09-01
Primary completion: 2010-10-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.